A World Without Rebates: Is FDA’s Gottlieb Offering New Vision?

US FDA Commissioner Gottlieb suggests administrative action to prohibit drug rebates as a way to lower drug prices. His remarks may preview an upcoming proposal from President Trump and HHS Secretary Azar.

More from Pricing Debate

More from Market Access